Picture of Effector Therapeutics logo

EFTR — Effector Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro Cap

Brief: EFFECTOR Therapeutics Announces Positive Top-Line Results From Phase 1b Clinical Trial Of Zotatifin

Feb 21 (Reuters) - eFFECTOR Therapeutics Inc  EFTR.O :
    * EFFECTOR THERAPEUTICS ANNOUNCES POSITIVE TOP-LINE RESULTS
FROM
PHASE 1B CLINICAL TRIAL OF ZOTATIFIN FOR THE TREATMENT OF COVID
    * EFFECTOR THERAPEUTICS - ZOTATIFIN FOR TREATMENT OF COVID
SHOWING
FAVORABLE SAFETY RESULTS, POSITIVE TRENDS IN SEVERAL MEASURES OF
ANTIVIRAL ACTIVITY

Source text for Eikon:  ID:nGNX50P5ZN 
Further company coverage:  EFTR.O 
 ((Reuters.Briefs@thomsonreuters.com;))

Recent news on Effector Therapeutics

See all news